5Dixon JM, Anderson TJ, Miller WR. Neoadiuvant endocrine therapy of breast cancer: a surgical perspective[J]. Eur J Cancer,2002,38(17) :2214-2221.
6Milla Santos A, Milla L,Calvo N, et al. Anastroloze as neoadjuvant therapy for patients with hormone-depend- ent, locally-advanced breast cancer. Anticancer Res [J]. 2004, 24(2C):1315-1318.
7Eiermann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole., a randomized double-blind multicenter study[J]. Ann Oncol,2001,12(11) : 1527-1532.
8Dixon JM,Love CD,Bellamy CO,et al. Letrozole as primary medical therapy for locally advanced and large operable breast cancer[J]. Breast Cancer ResTreat,2001, 66(3):191-199.
9Ellis MJ,Coop A, Singh B,et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for Erb-1 and/or Erb-2 positive, estrogen receptor positive primary breast cancer: evidence from a phase Ill randomized trial[J]. Clin Oncol,2001,19(18) : 3808-3816.
